Wednesday, July 8, 2026

Patent intelligence · US

US 7683188

Process for preparation of mycophenolic acid and ester derivatives thereof

granted A61PA61P37/06
Status granted
Linked drugs 1
Pipeline programs 6
Years to expiry 4
Applicant portfolio 454
Patent details — US 7683188

Quick answer

US 7683188 (Process for preparation of mycophenolic acid and ester derivatives thereof) is held by TEVA Gyógyszergyár Zártkörüen Müködö Részvénytárasaság. Status: granted. Granted Mar 23, 2010. Expires Mar 18, 2030 (4 years remaining) — relevant for patent-cliff and LOE planning.

Key facts

Grant date
Expiration
Claims
10
CPC classes
A61P, A61P37/06

More from TEVA Gyógyszergyár Zártkörüen Müködö Részvénytárasaság

Related pharmaceutical patents in our USPTO index.

  1. US 12310929

    Use of rasagiline for the treatment of restless legs syndrome

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Expires May 22, 2045

    granted
  2. US 12258401

    Anti-CD47 combination therapy

    TEVA PHARMACEUTICALS AUSTRALIA PTY LTD · Expires Mar 20, 2045

    granted
  3. US 12157729

    Solid state forms of Belumosudil and Belumosudil salts

    TEVA PHARMACEUTICALS INTERNATIONAL GMBH · Expires Nov 28, 2044

    granted
  4. US 12139528

    Treating refractory migraine

    TEVA PHARMACEUTICALS INTERNATIONAL GMBH · Expires Nov 7, 2044

    granted
  5. US 12091388

    Solid state forms of Reproxalap

    TEVA PHARMACEUTICALS INTERNATIONAL GMBH · Expires Sep 12, 2044

    granted
  6. US 11826322

    Pre-filled syringe

    Teva Pharmaceuticals USA, Inc. · Expires Nov 23, 2043

    granted
  7. US 11813359

    Sustained release olanzapine formulations

    TEVA PHARMACEUTICALS INTERNATIONAL GMBH · Expires Nov 9, 2043

    granted
  8. US 11773083

    Solid state forms of Belumosudil and Belumosudil salts

    TEVA PHARMACEUTICALS INTERNATIONAL GMBH · Expires Sep 28, 2043

    granted

Frequently asked questions

What is US patent 7683188?

US 7683188 (Process for preparation of mycophenolic acid and ester derivatives thereof) is held by TEVA Gyógyszergyár Zártkörüen Müködö Részvénytárasaság. Status: granted. Granted Mar 23, 2010. Expires Mar 18, 2030 (4 years remaining) — relevant for patent-cliff and LOE planning.

Who owns US 7683188?

TEVA Gyógyszergyár Zártkörüen Müködö Részvénytárasaság is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 454 pharmaceutical patents for this assignee.

When does US 7683188 expire?

Our index shows an expiration date of Mar 18, 2030 (4 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.